Arielis

Brand name drug sales soar in Canada, while R&D sags

Brand name drug sales soar in Canada, while R&D sags | CBC | December 01, 2017
Source: CBC
December 01, 2017
Canada's manufacturers of brand name medicines have failed to invest 10 per cent of their annual sales into research and development as they have long promised. The industry earned a record $20 billion in 2016, yet spent just four per cent of that on in-house R&D in Canada.

Read Full Story
Popular Articles